Nectar Lifesciences Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21	Sep ' 20

Sales

792.09

791.67

919.23

749.02

816.16

Operating profit

62.41

34.44

95.74

63.10

48.21

Interest

38.14

42.35

35.06

43.75

55.75

Gross profit

35.34

3.16

61.73

29.59

-6.49

EPS (Rs)

0.13

-0.83

0.95

0.18

-1.08

Other income

11.08

11.07

1.05

10.24

1.05

Stock adjustment

27.14

-22.51

16.07

-1.10

45.95

Raw material

539.81

620.77

658.10

548.78

576.55

Power and fuel

-

-

-

-

-

Employee expenses

39.11

37.75

38.94

35.61

36.03

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

123.62

121.21

110.38

102.64

109.42

Provisions made

-

-

-

-

-

Depreciation

30.64

29.49

28.54

28.43

30.14

Taxation

1.86

-7.79

11.81

-2.78

-12.50

Net profit / loss

2.84

-18.53

21.39

3.93

-24.13

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

22.43

22.43

22.43

22.43

22.43

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

7.88

4.35

10.42

8.42

5.91

GPM (%)

4.40

.39

6.71

3.90

-.79

NPM (%)

0.35

-2.31

2.32

0.52

-2.95